CCS
CORZ icon

Concentric Capital Strategies’s Core Scientific CORZ Stock Holding History

Concentric Capital Strategies’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-422,779
Closed -$5.94M – 190
2024
Q4 		$5.94M Buy
+422,779
New +$6.25M 0.27% 93

Other funds holding CORZ

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
GC
Gullane Capital Memphis, Tennessee $37.4M AUM 112.18% 1-Year Est. Return
OWP
ORG Wealth Partners Dallas, Texas $668M AUM 45.71% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
JCM
JAT Capital Management Greenwich, Connecticut $59.3M AUM 134.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return

Concentric Capital Strategies's CORZ Position: Q1 2025 in Review

Concentric Capital Strategies sold out of Core Scientific (CORZ) in Q1 2025, closing a stake of 422,779 shares — an estimated $5.94M sold.

Concentric Capital Strategies first reported a position in CORZ in Q4 2024 and held it in 1 quarter. The position peaked at $5.94M in Q4 2024. 336 funds tracked by Wall St. Rank hold CORZ as of Q1 2025.

  • Concentric Capital Strategies reported no remaining Core Scientific position as of Q1 2025 after selling out during the quarter.
  • Concentric Capital Strategies sold 422,779 Core Scientific shares in Q1 2025, an estimated $5.94M.
  • Concentric Capital Strategies first reported a position in Core Scientific in Q4 2024 and held it in 1 quarter.
  • Concentric Capital Strategies's Core Scientific position peaked at $5.94M in Q4 2024.
  • 336 funds tracked by Wall St. Rank held Core Scientific as of Q1 2025.

Based on Concentric Capital Strategies's 13F filing for Q1 2025, filed 15 May 2025.